0001362118-23-000002.txt : 20230105 0001362118-23-000002.hdr.sgml : 20230105 20230105104117 ACCESSION NUMBER: 0001362118-23-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230105 DATE AS OF CHANGE: 20230105 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FRIEDEMAN JESSICA CENTRAL INDEX KEY: 0001960450 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39785 FILM NUMBER: 23510076 MAIL ADDRESS: STREET 1: C/O LIFEMD STREET 2: 236 FIFTH AVENUE, SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeMD, Inc. CENTRAL INDEX KEY: 0000948320 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 760238453 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: (866) 351-5907 MAIL ADDRESS: STREET 1: 236 FIFTH AVENUE STREET 2: SUITE 400 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: CONVERSION LABS, INC. DATE OF NAME CHANGE: 20180622 FORMER COMPANY: FORMER CONFORMED NAME: Immudyne, Inc. DATE OF NAME CHANGE: 20120514 FORMER COMPANY: FORMER CONFORMED NAME: IMMUDYNE INC DATE OF NAME CHANGE: 19950720 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2023-01-03 0 0000948320 LifeMD, Inc. LFMD 0001960450 FRIEDEMAN JESSICA C/O LIFEMD 236 FIFTH AVENUE, SUITE 400 NEW YORK NY 10001 0 1 0 0 Chief Marketing Officer Common Stock 2023-01-03 4 A 0 150000 A 150000 D Pursuant to the Company's 2020 Equity and Incentive Plan, as amended, the reporting person received a grant of 150,000 restricted shares, with 50,000 vesting on January 3, 2024, 50,000 vesting on January 3, 2025 and 50,000 vesting on January 3, 2026. /s/ Jessica Friedeman 2023-01-05